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 Abstract
The present study aimed to determine the relationship between subclinical hypothyroidism and diabetic 
retinopathy in patients with type 2 diabetes mellitus. In this cross-sectional analytical study, 150 patients 
with type 2 diabetes mellitus were assessed. The eye fundus examination was performed using fundoscopy 
to confirm or rule out retinopathy. Thyroid hormones were also measured by special kits to diagnose 
subclinical hypothyroidism. The criteria for diagnosis of this disorder include the high serum thyrotropin 
concentration (≥ 4mIU/L) plus normal serum free thyroxin levels. Statistical analyses were done using IBM-
SPSS. In the study, 34.66% suffered retinopathy. A total of 24.0% suffered subclinical hypothyroidism with 
higher prevalence rate in those with retinopathy as compared with the group without retinopathy (p = 0.001). 
Those with diabetic retinopathy also experienced longer duration of diabetes than those without this event. 
(p = 0.006). Analysis show a significant role for type 2 diabetes mellitus (OR = 1.121, P = 0.003), and high 
TSH level (OR = 1.342, P = 0.006) to predict diabetic retinopathy.This study showed an association between 
hypothyroidism, diabetes and increased TSH with retinopathy. Retinopathy is significantly predicable with 
the presence of subclinical hypothyroidism and longer duration of diabetes. 
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 Introduction
Type 2 diabetes mellitus is a major group of 
disorders characterized by varying degrees of insulin 
resistance, reduced insulin secretion and increased 
glucose production that affects around 285 million 
people worldwide in 2010, with a rapidly increasing 
prevalence around the world (1) . The prevalence of this 
phenomenon is 0.2% in people under age 20, 11.3% 
in people over the age of 20 and 26.9% in people over 
65 years of age. Meanwhile, due to an increase in the 
prevalence of obesity and a decrease in physical activity, 
the increase in the prevalence of type 2 diabetes mellitus 
has been higher than imagined (2). In diabetic patients, 
there are many acute and chronic complications that 
can be attributed to cardiovascular, renal, neurological, 
infectious and ocular complications (1, 3) . Diabetic 
retinopathy is an ophthalmologic complication of 
diabetes mellitus and one of the causes of blindness 
in people with this disease (1, 4). Prolonged diabetes, 
poorly controlled blood glucose, advanced age, male 
gender, increased systolic blood pressure, consuming 
antihypertensive medications can increase the likelihood 
of diabetic retinopathy (5). Given that the prevalence 
of diabetes is increasing, the progression of diabetic 
retinopathy is also rising as one of the microvascular 
complications of diabetes mellitus (6). The prevalence 
of retinopathy, non-proliferative retinopathy and 
proliferative retinopathy was 3.1%, 1.1% and 0.1% in 
the general population and 23%, 19.1% and 8.2% in 
the diabetic population, respectively. Since the most 
effective treatment for diabetic retinopathy is to prevent 
it, the importance of identifying risk factors and the 
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causes of increased prevalence of diabetic retinopathy 
is clarified (2, 4). The thyroid plays an important role 
in the body’s metabolism (7) and recently suggested 
that the prevalence of people with thyroid disorders, 
especially subclinical hypothyroidism, was significantly 
higher in people with type 2 diabetes mellitus. 
Subclinical hypothyroidism is an asymptomatic stage 
of hypothyroidism characterized by elevated serum 
thyrotropin levels and serum free thyroxine levels (8).
Patients with subclinical hypothyroidism have an 
endothelial dysfunction, which may lead to dysfunction 
of the small veins as the main fundament of retinopathy 
(8, 9). Some Studies demonstrated association between 
high thyroid stimulating hormone (TSH) levels and an 
increased risk of diabetic (10, 11) and some studies do 
not show this relationship (12) For this reason, in many 
studies, it is recommended that people with thyroid 
disorders, especially subclinical hypothyroidism, should 
be screened for retinopathy so that the condition can 
be given to health authorities in a controlled manner. 
Therefore, due to the high prevalence of diabetes and 
hypothyroidism and various complications due to the 
lack of control of diabetes, especially retinopathy, and the 
possible association of these two diseases with diabetic 
retinopathy, the present study aimed to determine the 
relationship between subclinical hypothyroidism and 
diabetic retinopathy in patients with type 2 diabetes 
mellitus.  
Materials and Methods
Study design: In this cross-sectional analytical 
study, 150 patients with type 2 diabetes mellitus who 
referred to the internal clinic of Kowsar Hospital of 
Semnan between 2013 and 2014, with the preservation 
of inclusion and exclusion criteria were assessed. 
The sampling method was convenience sampling. 
Furthermore, data were collected through a questionnaire 
and Para clinical results.
Inclusionand exclusion criteria: The inclusion 
criteria were having type II diabetes mellitus, disease 
duration ranged 2 to 5 years, serum hemoglobin A1C 
6.5% or higher, lack of clinical manifestations of thyroid 
disorders including fatigue, malaise, skin dryness, 
puffiness of face and hands, lack of laboratory findings 
related to thyroid disorders including raised TSH level 
along with reduced free T4, and conscious consent to 
participate in the study. In this regard, those with the 
history of cancer, liver or kidney disorders, chronic 
infections, using the drugs affecting thyroid functions 
(such as glucocorticoids, oral contraceptives, or 
NSAIDS) were all excluded from the study. 
Study protocol and Biologic samples: After 
taking the medical records including demographics, 
medical history and medications, a clinical examination 
was performed to determine height, weight and blood 
pressure. Also, thyroid stimulating hormone (TSH), 
free thyroxine (free T4), hemoglobin A1C (HBA1C) 
and fasting blood glucose (FBS) were measured at the 
hospital laboratory using the special kits. TSH and T4 
levels were measured by radioimmunoassay technique. 
HBA1C was measured by high-performance liquid 
chromatography (HPLC). FBS Fasting blood glucose 
was also measured by a glucose oxidase method. The eye 
fundus examination was performed using fundoscopy. 
The information was included in the data collection 
forms, which was previously prepared by the researcher 
for this purpose. This work continued until the sample 
volume was completed. 
Data collection: Venous blood samples were collected 
in test tubes containing clot activator, immediately stored 
on ice, and—one hour after collection—centrifuged at 
4000 rpm for 10 minutes. Plasma were separated and 
stored at −80°C through the hour to be analyzed. Those 
with normal free thyroxine (FT4) and an increased TSH 
(≥4 μIU/ml) level were diagnosed with SCH. Digital 
retinal photographs (two eyes × two fields), taken using 
a TRC-NW7SF (Topcon, Tokyo, Japan) non-mydriatic 
camera at 45°, were examined independently by two 
qualified retinal photography graders following quality 
assurance protocols. The severity of diabetic retinopathy 
was graded based on the international clinical diabetic 
retinopathy severity scale. data of patients and laboratory 
results were recorded in a pre-designed information form 
and finally entered for statistical analysis.
Statistical analysis: Descriptive analysis was used to 
describe the data, including mean ± standard deviation 
(SD) for quantitative variables and frequency for 
categorical variables. Chi square test, independent t test 
were used for comparison of variables. The correlation 
between quantitative variables was tested by the 
Pearson’s correlation test. For the statistical analysis, the 
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statistical software IBM SPSS Statistics for Windows 
version 25.0 was used. P values <0.05 were considered 
statistically significant. 
Findings
In this study, 150 patients with type 2 diabetes 
mellitus were analyzed. The mean age of patients was 
57.94 ± 9.68 years including 93 men (62.0%) and 57 
females (38.0%). Of the participants in the study, 52 
(34.66%) suffered retinopathy. None of the patients has 
overt or clinical hypothyroidism. Comparing baseline 
characteristics between the patients with and without 
retinopathy showed no difference in patients’ age (p = 
0.232), gender (p = 0.329), body mass index (p = 0.431) 
(Table 1). 
Table 1: Comparing baseline characteristics between the groups with and without retinopathy




< 50 years 5 (9.6) 25 (25.5)
50-59 years 19 (36.5) 41 (41.8)
60-69 years 16 (23.1) 21 (21.5)
≥ 70 years 12 (23.1) 11 (11.2)
Female gender 34 (65.4) 59 (60.2) 0.329
Disease duration 13.73 ± 1.06 9.03 ± 0.51 0.006
5-10 years 25 (48.1) 70 (71.4)
11-20 years 18 (34.6) 23 (23.5)
21-30 years 8 (15.4) 5 (5.1)
>30 years 1 (1.9) 0 (0.0)
Body mass index 26.21 ± 0.58 25.63 ± 0.46 0.431
< 25 kg/m2 22 (42.3) 44 (44.9)
25-29.9 kg/m2 19 (36.5) 33 (33.7)
≥ 30 kg/m2 11 (21.2) 21 (21.4)
Results showed that subclinical hypothyroidism is associated with retinopathy and this relationship is statistically 
significant. No significant correlation systolic blood pressure (p = 0.365), diastolic blood pressure (p = 0.685), 
the level of fasting blood sugar (p = 0.401), and HBA1C level (p = 0.466), while those with diabetic retinopathy 
experienced longer duration of diabetes than those without this event. (13.73 ± 1.06 years versus 9.03 ± 0.51 years, 
p = 0.006). The mean level of TSH in the patients with and without retinopathy was 4.68 ± 0.96 and 2.13 ±0.18 with 
significant difference (p = 0.006) (Table 2).  
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Table 2 Comparing Biochemical characteristics
Item Group with retinopathy
Group without 
retinopathy P value
Mean systolic blood pressure, mmHg 127.00 ± 2.00 123.44 ± 1.31 0.365
Mean diastolic blood pressure, mmHg 78.60 ± 1.15 78.79 ± 0.85 0.658
Fasting blood sugar, mg/dl 159.52 ± 13.06 148.81 ± 5.62 0.401
< 100 mg/dl 11 (21.2) 14 (14.3)
100-126 mg/dl 11 (21.2) 29 (29.6)
>126 mg/dl 30 (57.7) 55 (56.1)
Mean hemoglobin A1C 7.89 ± 0.20 7.77 ± 0.16 0.466
Mean TSH level 4.68 ± 0.96 2.13 ± 0.18 0.006
Prevalence of hypothyroidism 36 (24.0) 22 (42.3) 0.001
A total of 36 patients (24.0%) suffered subclinical hypothyroidism with higher prevalence rate in those with 
retinopathy as compared with the group without retinopathy (42.3% versus 14.3%). However, there was no difference 
in the level of T4 between the patients with and without diabetic retinopathy (1.10 ± 0.04 ng/dL versus 1.20 ± 0.02 
ng/dL, p = 0.222). In order to investigate the relationship between the mentioned variables on retinopathy, logistic 
regression analysis showed that type 2 diabetes mellitus was significantly associated with retinopathy (OR = 1.121, 
95%CI: 1.041 – 1.208, P = 0.003), and high TSH level (OR = 1.342, 95%CI: 1.086 – 1.657, P = 0.006) to predict 
diabetic retinopathy (Table 3). 
Table 2: Multivariable logistic regression model to predict diabetic retinopathy
Item Beta Wald P value Lower limit Upper limit
Age 0.014 0.378 0.540 0.969 1.063
Gender -0.048 0.013 0.909 0.418 2.174
Type 2 diabetes mellitus 0.115 9.119 0.003 1.041 1.208
Systolic blood pressure 0.028 2.827 0.093 0.995 1.063
Diastolic blood pressure -0.024 0.850 0.357 0.927 1.028
Body mass index 0.063 1.883 0.170 0.973 1.165
Fasting blood sugar 0.001 0.027 0.870 0.994 1.007
Hemoglobin A1C -0.025 0.028 0.867 0.724 1.312
Free T4 -0.530 0.484 0.486 0.133 2.616
TSH 0.294 7.454 0.006 1.086 1.687
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Discussion
In our study, it was found that subclinical 
hypothyroidism is directly and significantly associated 
with retinopathy. Also, retinopathy was directly and 
significantly associated with Type 2 diabetes mellitus 
and TSH levels. Coherent research has shown Patients 
with subclinical hypothyroidism have an endothelial 
dysfunction, which may lead to inappropriate operation 
of small veins increasing the likelihood of retinopathy 
(8, 9). The association between thyroid hormone levels 
and retinopathy has been observed in other studies (10, 11, 
13). For this reason, in many studies, it is recommended 
that people with thyroid disorders, especially subclinical 
hypothyroidism should be screened for retinopathy. In 
study on 1581 subjects with normal thyroid function, 
the results showed that TSH levels had a positive 
correlation with insulin resistance and, as a result, with 
diabetic retinopathy (14) .In another study conducted 
on the Beijing Tongren Hospital of China on 1,117 
patients with type 2 diabetes mellitus, it was found 
that the prevalence of diabetic retinopathy in people 
with subclinical hypothyroidism was higher than those 
with normal thyroid (9). Also, although the level of 
fasting blood glucose and hypertension are known to 
be two factors affecting diabetes (15-17), Yuedong Hu 
(2015) noted that these two factors had no meaningful 
relationship with diabetic retinopathy (18). Moreover, in a 
study of 11140 patients with type 2 diabetes mellitus, the 
results showed that control of blood pressure below the 
normal level, even for 5 years, had no significant effect 
on the prevalence of diabetic retinopathy (19) , which was 
similar to our findings. In a study conducted by Javadi et 
al. (2009) in Saudi Arabia, more than 50% of people with 
diabetic retinopathy were older than 60 years of age (20), 
which was also similar to our study results. Similarly, in 
a study by Khalid Al-Rubeaan et al. (2015), unlike our 
study, the prevalence of diabetic retinopathy in males was 
more than females (21). The reason for this was the lower 
number of males in our study than the similar studies, 
which reduced the likelihood of diabetic retinopathy in 
men. additionally, obesity is a problem because of the 
direct relationship with diabetes (22, 23) . In this regard, 
Studies noted that the BMI of diabetic individuals had a 
meaningful relationship with diabetic retinopathy (21, 24, 
25), but in our study, there was no significant relationship 
between BMI and risk for retinopathy. 
One of the most important limitations of this 
study was its cross-sectional nature that limited the 
outcome analysis. Another limitation in this study was 
the relatively small number of statistical samples that 
should be cautious about generalizing its outcomes to 
other individuals and populations. Also, in this study, 
the definition and division of obesity has been done 
based on the BMI of individuals; while this index does 
not differentiate between muscle distribution and fat 
distribution. Even the distribution of fat in different parts 
of the body could have changed the risk of developing 
diabetes in different individuals, as the results of various 
studies indicate that the distribution of fat levels in the 
upper and lower abdomen, the risk Metabolic diseases, 
especially diabetes, are increased more than those who 
have a fat mass in the lower parts of the body (26-29). 
One of the other limitations of this study was the 
lack of examination of a number of diabetes-related 
factors mentioned in other studies, including smoking, as 
well as exercise and physical activity, which, of course, 
due to the limited means of measuring this study. Also, 
the treatment of diabetics (insulin or oral medication) 
was another issue that could not be verified due to the 
limitations of this study.
Conclusion
Subclinical hypothyroidism is associated with 
diabetic retinopathy in type 2 diabetic patients. There is 
a positive correlation between level of TSH and Intensity 
of diabetic retinopathy in type 2 diabetics with subclinical 
hypothyroidism. Also, subclinical hypothyroidism was 
one factor that significantly increased the risk of diabetic 
retinopathy. Therefore, considering the high prevalence 
of diabetic retinopathy and its relation to the subclinical 
hypothyroidism, planning for the education of patients 
at risk for diabetes or diabetic patients regarding long-
term complications of diabetes, especially retinopathy is 
essential.  
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